Skip to content
Govbase
Govbase
Congress·In Progress·H.R. 2821

FDA Modernization Act 3.0

FDA Rules: Updating Drug Testing Methods

The FDA Modernization Act 3.0 is currently in the early stages of the legislative process. It was recently sent to the House Committee on Energy and Commerce for review. The bill is actively moving forward as it waits for the committee to discuss and vote on it.

Legislative Progress

House
Senate
President
Law
Likely to pass

This bill has support from both parties and simply helps the FDA follow a law that was already passed. It fixes technical issues and updates rulebooks to match current policy.

Key Points

  • This bill requires the FDA to update its official rulebooks within one year. It changes the wording from animal tests to nonclinical tests. This allows for modern technology like computer models or lab-grown human cells to be used in research.
  • Drug companies and researchers are the main groups affected. They will have clearer rules on how to use new technology to prove a drug is safe. This means they might not always need to test new medicines on animals first.
  • This matters because it helps finish a job started by a law passed in 2023. By using modern methods instead of just animal testing, scientists might find faster and more accurate ways to see if a drug is safe for people.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

4 milestones7 actions
May 21, 2026House

Ordered to be Reported by the Yeas and Nays: 44 - 0.

The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.

May 21, 2026House

Committee Consideration and Mark-up Session Held

May 13, 2026House

Forwarded by Subcommittee to Full Committee by Voice Vote.

May 13, 2026House

Subcommittee Consideration and Mark-up Session Held

Apr 10, 2026House

Referred to the Subcommittee on Health.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Votes

No votes have been recorded for this legislation yet.

News

No related news coverage found for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

FDA Modernization Act 3.0

Bill NumberHR 2821
Congress119th Congress
ChamberHouse of Representatives
Latest ActionOrdered to be Reported by the Yeas and Nays: 44 - 0.

Sponsor

Cosponsors

(40)
D: 20R: 20

Analysis generated by AI. Always verify with official sources.